The activation of the MAPK pathway promotes cell proliferation and survival, and MAP2K2 is also considered a cancer-predisposing gene, as in Noonan syndrome (Alba-Pavón et al., 2023; Cavé et al., 2016). Here, MAP2K2 is linked to Noonan syndrome.